Venus Concept Inc.
General ticker "VERO" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $2.5M (TTM average)
Venus Concept Inc. does not follow the US Stock Market performance with the rate: -0.8%.
Estimated limits based on current volatility of 2.8%: low 1.84$, high 1.94$
Factors to consider:
- Total employees count: 304 (-20.8%) as of 2023
- US accounted for 56.9% of revenue in the fiscal year ended 2023-12-31
- Top business risk factors: Operational and conduct risks, Labor/talent shortage/retention, Geopolitical risks, Supply chain disruptions, Economic downturns and volatility
- Current price 21.8% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.48$, 8.33$]
- 2025-12-31 to 2026-12-31 estimated range: [1.60$, 5.54$]
Financial Metrics affecting the VERO estimates:
- Positive: with PPE of -0.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -414.73 <= 0.33
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
- Negative: negative Industry operating cash flow (median)
Short-term VERO quotes
Long-term VERO plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $99.50MM | $76.35MM | $64.83MM |
| Operating Expenses | $134.37MM | $104.66MM | $92.02MM |
| Operating Income | $-34.88MM | $-28.31MM | $-27.18MM |
| Non-Operating Income | $-9.43MM | $-8.81MM | $-20.40MM |
| Interest Expense | $4.56MM | $6.89MM | $7.66MM |
| R&D Expense | $10.95MM | $8.20MM | $6.69MM |
| Income(Loss) | $-44.31MM | $-37.12MM | $-47.58MM |
| Taxes | $-0.72MM | $-0.07MM | $-0.61MM |
| Profit(Loss)* | $-43.70MM | $-37.25MM | $-47.00MM |
| Stockholders Equity | $8.09MM | $-14.02MM | $2.37MM |
| Inventory | $29.79MM | $28.68MM | $17.56MM |
| Assets | $125.38MM | $93.65MM | $68.18MM |
| Operating Cash Flow | $-26.98MM | $-12.86MM | $-11.07MM |
| Capital expenditure | $0.34MM | $0.12MM | $0.12MM |
| Investing Cash Flow | $-0.34MM | $-0.12MM | $-0.12MM |
| Financing Cash Flow | $8.01MM | $6.80MM | $10.06MM |
| Earnings Per Share** | $-9.94 | $-6.84 | $-66.28 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.